Spoor Jochem K H, den Braber May, Dirven Clemens M F, Pennycuick Adam, Bartkova Jirina, Bartek Jiri, van Dis Vera, van den Bosch Thierry P P, Leenstra Sieger, Venkatesan Subramanian
Department of Neurosurgery, Brain Tumor Center, Erasmus University Medical Center, Rotterdam, Netherlands.
Department of Paediatric Neurosurgery, Erasmus Medical Center Sophia Children's Hospital, Rotterdam, Netherlands.
Front Oncol. 2024 Jan 8;13:1218297. doi: 10.3389/fonc.2023.1218297. eCollection 2023.
Only a small group of patients with glioblastoma multiforme (GBM) survives more than 36 months, so-called long-term survivors. Recent studies have shown that chromosomal instability (CIN) plays a prognostic and predictive role among different cancer types. Here, we compared histological (chromosome missegregation) and bioinformatic metrics (CIN signatures) of CIN in tumors of GBM typical survivors (≤36 months overall survival), GBM long-term survivors and isocitrate dehydrogenase (IDH)-mutant grade 4 astrocytomas.
Tumor sections of all gliomas were examined for anaphases and chromosome missegregation. Further CIN signature activity analysis in the The Cancer Genome Atlas (TCGA)-GBM cohort was performed.
Our data show that chromosome missegregation is pervasive in high grade gliomas and is not different between the 3 groups. We find only limited evidence of altered CIN levels in tumors of GBM long-term survivors relative to the other groups, since a significant depletion in CIN signature 11 relative to GBM typical survivors was the only alteration detected. In contrast, within IDH-mutant grade 4 astrocytomas we detected a significant enrichment of CIN signature 5 and 10 activities and a depletion of CIN signature 1 activity relative to tumors of GBM typical survivors.
Our data suggest that CIN is pervasive in high grade gliomas, however this is unlikely to be a major contributor to the phenomenon of long-term survivorship in GBM. Nevertheless, further evaluation of specific types of CIN (signatures) could have prognostic value in patients suffering from grade 4 gliomas.
只有一小部分多形性胶质母细胞瘤(GBM)患者存活超过36个月,即所谓的长期幸存者。最近的研究表明,染色体不稳定性(CIN)在不同癌症类型中具有预后和预测作用。在此,我们比较了GBM典型幸存者(总生存期≤36个月)、GBM长期幸存者以及异柠檬酸脱氢酶(IDH)突变的4级星形细胞瘤肿瘤中CIN的组织学(染色体错分离)和生物信息学指标(CIN特征)。
检查所有胶质瘤的肿瘤切片的后期和染色体错分离情况。在癌症基因组图谱(TCGA)-GBM队列中进行进一步的CIN特征活性分析。
我们的数据表明,染色体错分离在高级别胶质瘤中普遍存在,且在三组之间没有差异。相对于其他组,我们仅发现有限的证据表明GBM长期幸存者肿瘤中的CIN水平发生改变,因为相对于GBM典型幸存者,CIN特征11的显著减少是唯一检测到的改变。相比之下,在IDH突变的4级星形细胞瘤中,相对于GBM典型幸存者的肿瘤,我们检测到CIN特征5和10活性显著富集,而CIN特征1活性减少。
我们的数据表明,CIN在高级别胶质瘤中普遍存在,但这不太可能是GBM长期生存现象的主要促成因素。尽管如此,对特定类型的CIN(特征)进行进一步评估可能对患有4级胶质瘤的患者具有预后价值。